The IQVIA Podcast

Sarah Rickwood is joined by Elyse Muñoz, IQVIA’s US Director of Research & Insights, to discuss the first of a three-part launch excellence series on the current state of US launch and the new rules for launching excellently in the US, the most important market for global innovative medicines success.

Dive into the world of data management with “Consumer Health Edge” podcast’s latest episode, “Mastering Data; A Beginner’s Guide to Information Management.” Join host Vaishnavi Save as she welcomes Antonello Moscatelli, a seasoned expert with nearly two decades of experience in Data and Analytics. Together, they explore the crucial steps organizations must take to implement effective information management strategies. From aligning data strategy with business objectives to assessing the data landscape and ensuring security and compliance, this episode offers actionable insights and practical tips. Discover how to harness the power of data to drive informed decision-making, enhance efficiency, and gain a competitive edge in today’s dynamic market landscape. Tune in and empower your organization with the knowledge to unlock the full potential of your data assets.

Dr. Larisse Prinsen provides an overview of challenges, changes required, and implications of the NHI, from a legal perspective.

Rare Diseases, though individually uncommon, collectively affect a significant number of people. In the Middle East, these conditions present a unique set of challenges and opportunities. Tune into the first of our 2-part podcast as we uncover how the Middle East is tackling these uncommon conditions and shed the light on what rare diseases mean to the region, from healthcare challenges to the latest advancements.

Rare Diseases, though individually uncommon, collectively affect a significant number of people. In the Middle East, these conditions present a unique set of challenges and opportunities. Tune into the final part of our podcast as we uncover how the Middle East is tackling these uncommon conditions and shed the light on what rare diseases mean to the region, from healthcare challenges to the latest advancements.

In Episode 2 of our Consumer Health Edge podcast, Vaishnavi Save and Ankit Gupta delve into the dynamic world of data-driven customer journeys, sales, and distribution. We uncover the pivotal role of data analytics in optimizing shelf space for consumer health companies, suggesting how tools revolutionize in-store strategies. Understanding the consumer journey is paramount, with insights gathered from loyalty programs, social platforms, and primary market research. We explore the meticulous process of cleansing and storing data, essential for extracting actionable insights through diagnostic, descriptive, predictive, and prescriptive analytics. Moreover, we unravel the nuanced landscape of sales and distribution optimization, where data empowers companies to fine-tune their strategies, maximize revenue, and identify growth opportunities. Join us as we unravel the intricate web of data-driven healthcare strategies, offering a glimpse into the future of the industry.

Prof. Nicholas Crisp discusses South Africa's National Health Insurance, its potential, the reforms, changes, challenges, and the roles of the public and private sectors.

IQVIA invited Eric Grant, the Communications and Media Manager for the Union for International Cancer Control (UICC), to delve into the critical issue of the cancer care gap in low- and middle-income countries (LMICs) across the Middle East and Africa, shedding light on the challenges these countries encounter while striving to bridge this gap and the efforts being made.

Welcome back to IQVIA Digital Enablement’s podcast series: Personalization Science. This is part 2 of our conversation with Jason Patterson, Chief Analytics Officer at Publicis Health Media. This time, host Andrew Burkus, leads an insightful discussion on the future of measurement and optimization, the role AI may play in this evolution, and how all these elements will continue to drive better health outcomes. Learn more about IQVIA Digital Enablement here: https://www.iqvia.com/locations/united-states/solutions/digital-enablement-center-of-excellence

Prof. Roseanne Harris, Health Policy Actuary at Discovery Health, discusses South Africa's National Health Insurance, its potential, the reforms and changes, and the roles of the public and private sectors.

Welcome back to IQVIA Digital Enablement’s podcast series: Personalization Science. This week, we are joined by Jason Patterson, Chief Analytics Officer at Publicis Health Media, a top healthcare media agency built for the modern marketplace. In part 1 of this conversation, host Andrew Burkus and Jason dive into the world of healthcare media optimization, misconceptions in the industry, and how continuous optimization differs from campaign measurement. 

Learn more about IQVIA Digital Enablement here: https://www.iqvia.com/locations/united-states/solutions/digital-enablement-center-of-excellence 

IQVIA South Africa General Manager Sandri Yssel presents an overview of the South Africa National Health Insurance Program and the podcast series.

In the first episode of IQVIA Digital Enablement’s new podcast series, host Andrew Burkus, Sr. Principal, is joined by Amanda Powers-Han, Chief Marketing Officer at Greater Than One, a leading marketing communications agency dedicated to healthcare. Tune in as these industry experts define what personalization is, why it is essential for your audience engagement strategy, and how to drive better outcomes in healthcare and life sciences marketing. Learn more about IQVIA Digital Enablement here: https://www.iqvia.com/locations/united-states/solutions/digital-enablement-center-of-excellence

What if clinical trial sites could focus entirely on research? What if sponsors could have immediate access to trial patients during and after the study, and use those insights to improve trial design? What if all of that could be done without burdening an already strained site? What if those didn’t have to be “what ifs”?  

In this sponsored episode of The Top Line, Julia Douthart talks to Jessica Jones, Director of Strategic Technology Delivery and Experience Optimization at IQVIA, about how new technologies are changing clinical trials, reducing the administrative burden on staff and improving insights for sponsors.

But can it be done without adding an additional technological burden and learning curve on the site staff? Listen below to learn how IQVIA is addressing these challenges.

"Essentially, this allows our clinical researchers to improve the chances of success for the trial leading to faster, more efficient drug development… Ultimately, this is going to benefit patients.”

Greg Lever is speaking about the use of flexible modeling to allow real-time changes to be made to clinical trial design and processes. 

As a director within the IQVIA Applied Data Science Center, and with over a dozen years of experience in the field, Greg knows the importance of data and advanced analytics in generating accurate patient insights to underpin key trial decision-making.

By making clinical trials more patient friendly, he states, the more likely it is that research organizations will be able to attract and retain the participants they need to bring life-saving treatments to patients.

In this podcast, Greg outlines how modeling can be used to enhance the entire patient journey, from the initial giving of informed consent right through to the trial’s close.

In this episode, Sarah Rickwood and Kirstie Scott discuss key findings from the “Success Multiplied: Launch Excellence for Multi-Indication Assets” white paper. Learn about the specific challenges multi-indication assets face, such as sequencing and speed of indication roll-out, performance consistency across multiple indications and promotional investment strategies to capture pan-indication synergies.

In part two, Andrew Jones shares just how much data is available in IQVIA’s Infinite Dimension Profiler. Tune in and learn how you can build healthcare professional profiles that include both professional and personal dimensions. He also shares how the platform opens up data silos, relieving IT headaches, and allows you to build true omnichannel programs. If you missed part one, catch up for an overview of the Infinite Dimension Profiler.   

Featured Speakers:

Do you have a complete picture of the healthcare professionals (HCPs) in your universe? Are you able to dynamically target and message them as market events change? If you don’t, or even if you think you do, tune into this podcast where IQVIA’s Kathleen Aalderink and Andrew Jones discuss all things around joining and leveraging data to build and compare target audience profiles. You will hear how the Infinite Dimension Profiler will help you pinpoint the right HCPs, which in turn, increases the speed in which your therapies reach patients. Be sure to tune into part two; you’ll be impressed to hear about the incredible amount of data you can have at your fingertips.

Featured Speakers:

This final episode focuses on the authority of physician assistants and naturopathic physicians. The conversation goes beyond the latest state-level authority regulations and includes a sampling of the varying definitions of what a naturopathic physician is. The speakers also share insight into what you can expect around prescriptive authority in the future. Be sure to tune into this episode, but to get the most out of our Prescriptive Authority series, take the opportunity to listen to parts one and two as well.
 
Featured Speakers: 

Dive into the world of data-driven healthcare in the inaugural episode of "Consumer Health Edge." 

Join host Vaishnavi Save and industry expert Raj Jawalkar, with over two decades of experience, as we explore the game-changing role of predictive analytics. 

Discover strategies for sustainable success, the importance of a well-defined business objective, and the critical pillars of data transformation. Raj unravels the complexities of sourcing, processing, and integrating data for effective predictive models.

Raj also provides insights into customer analysis for diverse industry groups—sales, pharmacies, marketing, and e-commerce. Learn how companies leverage predictive models to enhance effectiveness and drive strategic decisions in these domains.

This episode speaks about the foundations of successful predictive analytics, offering tangible examples and expert insights. Don't miss out on this engaging discussion that unveils the intricate world of data-driven healthcare and its transformative impact on sales and marketing.

Tune in now for a journey through the evolving landscape of consumer health!

Eric Klaver, DCT Regulatory Director, shares how IQVIA supports investigators within the areas of clinical trial conduct and operations.

IQVIA’s Head of Medical Affairs Strategy, Reinhard Berkels, joins Sarah Rickwood on the podcast to discuss the expanding role of Medical Affairs in launch. Hear how Medical Affairs is evolving and emerging as a more strategic function which can make or break a launch, and why this means companies should re-evaluate the way medical is positioned within their organization.

In Episode 3, Sarah Rickwood interviews Cristina Alzaga-Chaudhry, IQVIA’s EMEA Lead of Commercial Strategy & Transformation. Learn about agile launch planning, how launch performance management has evolved, and leading edge key performance indicators.

During part two of the prescriptive authority series, the discussion focuses on the legislation that is driving changes affecting optometrists and psychologists. Tune in to learn how the changes affect the type of data you should be leveraging to help insure you remain compliant. 

Featured Speakers: 

AI for R&D: Episode 3 | Leveraging AI/ML to better predict an asset's success 
Featured Speaker: Greg Lever, Director of R&D Solutions, Applied Data Science Center, IQVIA 
Host: Susan Cokas 

In this episode: 

Thank you for joining us for our leadership podcast around IQVIA’s Artificial Intelligence and advanced analytics for research and development. We look forward to sharing even more insights on how data science is being applied to augment and accelerate the R&D process in future episodes.

During this episode, IQVIA subject matter experts will share insights around the recent trends in prescriptive authority. Their conversation will be centered on the legislation driving the changes, what the changes are, why the changes are occurring, and how you can comply with the regulations.

Featured Speakers: 

In this episode, Cal St. Denis, Global Director of Sustainability at Johnson & Johnson MedTech, discusses the importance of implementing sustainability agendas that build in sustainability initiatives and considerations at the front end in product design all the way through to packaging. Cal shares part of Johnson & Johnson’s sustainability journey and highlights how MedTech industry customers are evolving and now demanding insights into respective sustainability agendas.

Host: Michaela Miller, Practice Leader, U.S. MedTech Technology & Analytics, IQVIA

Featured Speaker:Cal St. Denis, Global Director, Sustainability, Johnson & Johnson MedTech

As life sciences companies continue to prioritize new, omnichannel-centric commercial and customer engagement models, the ability for small and emerging biopharma organizations (EBPs) to be nimble and agile (relative to larger pharma companies) presents a potential advantage. Because many of these organizations are not as constrained as some of their larger peers by the complexities of existing size and scale, there is an opportunity to develop these new models more quickly and effectively. However, to date, too few EBPs have truly excelled in this space. IQVIA’s Susan Kitlas, VP, Precommercial Team, and Frank Papaianni, VP, Small Pharma, join our host, Matthew Smith, Sr. Principal, New Commercial Models & Digital Health, to identify both leading practices and sensible first steps small and EBP organizations can take on their customer engagement model journeys in this episode of our Agile Brand Promotion podcast series.

This episode focuses on design analytics and how they can be used to assess study design decisions and identify risks prior to protocol approval. Knowing that a high number of protocols require at least one substantial, costly amendment— investing in optimizing your protocol upfront by applying design analytics is a great solution to reduce risk and ultimately increase the probability of success of your trial. Tammie Nguyen, Clinical Planning and Design Analytics Director is our featured speaker.